معدل الإصابة بسرطان عنق الرحم(Cervical Cancer)  بمستشفى صبراتة للأورام

Hanan Alhadi  Albib

doi:10.59743/jmset.v7i1.34

Authors

Hanan Alhadi Albib Department of Zoology, Faculty of Science, Zawia University, Zawia, Libya.

DOI:

https://doi.org/10.59743/jmset.v7i1.34

Keywords:

Cervical cancer, Sabratha, Human papillomavirus (HPV), Tumors

Abstract

Cervical cancer is among the malignant tumors, and it is very important to have regular and effective examinations to prevent it. Given the impact of cervical cancer, this statistical study was carried out to find out the extent of the incidence of cervical cancer among women of different ages with cervical cancer patients who visited Sabratha Cancer Hospital. The ages of the groups of women used in this study ranged between (18-83) during the whole four years (2014-2017) from records of Sabratha Oncology Hospital in western Libya, data were analyzed using descriptive analysis. The results reported that the number of cases of Cervical cancer reached 79 cases out of 105 cases for the total number of patients. The results indicate that the percentage of cervical cancer is high (75%) among different age groups of women. Through this, continuous periodic examination and use of Pap smears in public and private health facilities is recommended, along with awareness campaigns and education about the disease.

References

Akhtar S.S., Bakr A., Dawi S.A., and Huq I.U. (1993). Cancer in Libya- A retrospective study (1981-1985). African Journal of Medicine and Medical Sciences, 22(1): 17-24.

Andrus J.K., Sherris J., Fitzsimmons J.W., Kane M.A., and Aguado M.T. (2008). Introduction of human papillomavirus vaccines into developing countries-international strategies for funding and procurement. Vaccine, 26: K87-K92.

Anorlu R.I. (2008). Cervical cancer: the sub-Saharan African perspective. Reproductive Health Matters, 16(32): 41-49.

Arbyn M., Castellsagué X., de Sanjosé S., Bruni L., Saraiya M., Bray F., and Ferlay J. (2011). Worldwide burden of cervical cancer in 2008. Annals of Oncology, 22(12): 2675-2686.

Arbyn M., Walker A., and Meijer C.J. (2010). HPV-based cervical-cancer screening in China. The Lancet. Oncology, 11(12): 1112-1113.

Ben Khaial F., Bodalal Z., Elramli A., Elkhwsky F., Eltaguri A., and Bendardaf R. (2014). Cervical cancer in north-eastern Libya: 2000–2008. Journal of Obstetrics and Gynaecology, 34(6): 523-526.

Canavan T.P. and Doshi N.R. (2000). Cervical cancer. American Family Physician, 61(5): 1369-1376.

Clifford G., Franceschi S., Diaz M., Muñoz N., and Villa L.L. (2006). HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 24: S26-S34.

Cohen P.A., Jhingran A., Oaknin A., and Denny L. (2019). Cervical cancer. The Lancet, 393(10167): 169-182.

Eddy D.M. (1990). Screening for cervical cancer. Annals of Internal Medicine, 113(3): 214-226.

El Mistiri M., Salati M., Marcheselli L., Attia A., Habil S., Alhomri F., Spika D., Allemani C., and Federico M. (2015). Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry. Annals of Epidemiology, 25(8): 564-568.

Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., and Bray F. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5): E359-E386.

Ferrante J.M., Gonzalez E.C., Roetzheim R.G., Pal N., and Woodard L. (2000). Clinical and demographic predictors of late-stage cervical cancer. Archives of Family Medicine, 9(5): 439.

Gasparini R. and Panatto D. (2009). Cervical cancer: from Hippocrates through Rigoni-Stern to zur Hausen. Vaccine, 27: A4-5.

Goldie S.J., O'shea M., Campos N.G., Diaz M., Sweet S., and Kim S.Y. (2008). Health and economic outcomes of HPV 16, 18 vaccinations in 72 GAVI-eligible countries. Vaccine, 26(32): 4080-4093.

Greer B.E., Koh W.J., Abu-Rustum N.R., Apte S.M., Campos S.M., Chan, J.,Cho K.R., Copeland L., Crispense M.A., Dupont N., Eifel P.J., Gaffney D.K., Huh W.K., Kapp D.S., Lurain III J.R., Martin L., Morgan M.A., Morgan R.J., Mutch D., Remmenga S.W., Reynolds R.K., Small W., Teng N., and Valea F.A. (2010). Cervical cancer. Journal of the National Comprehensive Cancer Network, 8(12): 1388-1416.

Hweissa N.A. and Su T.T. (2018). Awareness of cervical cancer and socio‐demographic variations among women in Libya: An exploratory study in Az‐Zawiya city. European Journal of Cancer Care, 27(1): e12750.

Korbag M.S. (2020). A new study biological role of HPV infection, oral contraceptive use, sex hormones and bisphenol A and increase rate cancer of cervical in Libya. Journal of Medicinal and Chemical Sciences, 3(4): 354-362.

Munoz N., Bosch F.X., Castellsagué X., Díaz M., De Sanjose S., Hammouda D., Shah K.V., and Meijer C.J. (2004). Against which human papillomavirus types shall we vaccinate and screen?. The International Perspective: International Journal of Cancer, 111(2): 278-285.

Parkin D.M., Pisani P., and Ferlay J. (1999). Global cancer statistics. CA: A Cancer Journal for Clinicians, 449: 33-64.

Qiao Y.L., Sellors J.W., Eder P.S., Bao Y.P., Lim J.M., Zhao F.H., Weig B., Zhang W-H., Peck R.B., Li L., Chen F., Pan Q-P., and Lorincz A.T. (2008). A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. The Lancet Oncology, 9(10): 929-936.

Scarinci I.C., Garcia F.A., Kobetz E., Partridge E.E., Brandt H.M., Bell M.C., and Castle P.E. (2010). Cervical cancer prevention: new tools and old barriers. Cancer: Interdisciplinary International Journal of The American Cancer Society, 116(11): 2531-2542.

Waggoner S.E. (2003). Cervical cancer. The Lancet, 361(9376): 2217-2225.

Wong L.P., Wong Y.L., Low W.Y., Khoo E.M., and Shuib R. (2009). Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study. Singapore Medical Journal, 50(1): 49.

Yang B.H., Bray F.I., Parkin D.M., Sellors J.W., and Zhang Z.F. (2004). Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. International Journal of Cancer, 109(3): 418-424.‏